Clinical Trial Update: Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse [Phase 4]

View source ↗

Summary

Phase IV trial evaluating solifenacin vs placebo plus pessary for pelvic organ prolapse has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Hartford Hospital | Conditions: Pelvic Organ Prolapse | Phase 4 | Status: TERMINATED